The global Burn Care Market is projected to be valued at USD 2.79 billion in 2024 and reach US$ 4.23 billion by 2030, growing ...

Given this risk, we thought we'd take a look at whether MDJM (NASDAQ:UOKA) shareholders should be worried about its cash burn ...

So, the natural question for Mereo BioPharma Group (NASDAQ:MREO) shareholders is whether they should be concerned by its rate of cash burn. In this report, we will consider the co ...

But the harsh reality is that very many loss making companies burn through all their cash and go bankrupt. Given this risk, we thought we'd take a look at whether XBiotech (NASDAQ:XBIT) shareholders ...

Capricor's lead asset, deramiocel, targets DMD-related cardiomyopathy and faces key FDA milestones. Find out why CAPR stock ...

Shares of biotechnology company Prime Medicine, Inc. (PRME) fell 18% on Monday afternoon after the company announced a ...

Tourmaline Bio is well-funded, with cash runway into 2H 2027, minimizing near-term dilution risk for investors. Click here to ...

Allan Reine, the company's chief financial officer, has been named CEO and will become a member of the board. Jeff Marrazzo, another director, has been named executive chair. Prime's shares fell 8.2% ...

Biotechs have faced several challenging years with slumping valuations and a competitive funding environment. However, the latest slew of ...

FDA Commissioner Marty Makary announced Thursday that the agency will soon provide clear guidelines to vaccine manufacturers ...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at ...